TWD
ANIK icon

True Wealth Design’s Anika Therapeutics ANIK Stock Holding History

True Wealth Design’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.67K Sell
136
-6
-4% -$115 ﹤0.01% 1570
2026
Q2 		$2.08K Buy
142
+32
+29% +$474 ﹤0.01% 1676
2026
Q1 		$1.59K Buy
110
+40
+57% +$464 ﹤0.01% 1627
2025
Q4 		$673 Buy
70
+19
+37% +$182 ﹤0.01% 1851
2025
Q3 		$480 Buy
51
+42
+467% +$401 ﹤0.01% 2017
2025
Q2 		$96 Buy
+9
New +$114 ﹤0.01% 2247
2025
Q1 		– Sell
-29
Closed -$478 – 2652
2024
Q4 		$478 Buy
+29
New +$572 ﹤0.01% 1102

Other funds holding ANIK

B
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

True Wealth Design's ANIK Position: Q3 2026 in Review

True Wealth Design reduced its Anika Therapeutics (ANIK) stake by 4.2% in Q3 2026, selling an estimated $115 and leaving 136 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

True Wealth Design first reported a position in ANIK in Q4 2024 and has held it in 7 quarters since. 9 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

  • True Wealth Design held 136 shares of Anika Therapeutics worth $2.67K as of Q3 2026.
  • True Wealth Design sold 6 Anika Therapeutics shares in Q3 2026, an estimated $115.
  • Anika Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1570 holding.
  • True Wealth Design first reported a position in Anika Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 9 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.